Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Research output: Contribution to journal › Article › peer-review
Electronic versions
Documents
- 2017 Clinical_efficacy_of_intravitreal_aflibercept_paper
Accepted author manuscript, 407 KB, PDF document
Licence: CC BY-NC-ND Show licence
Links
- https://www.sciencedirect.com/science/article/pii/S0140673617311935
Final published version
Licence: Unspecified
DOI
| Original language | English |
|---|---|
| Pages (from-to) | 2193-2203 |
| Journal | The Lancet |
| Volume | 389 |
| Issue number | 10085 |
| Early online date | 7 May 2017 |
| DOIs | |
| Publication status | Published - 3 Jun 2017 |
Total downloads
No data available